Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Hemangiosarcoma × Paclitaxel × Clear all

Phase

Status

Completed 2 Withdrawn 1 Unknown 1 Terminated 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 40 Ovarian Neoplasms 33 Carcinoma, Non-Small-Cell Lung 32 Stomach Neoplasms 27 Esophageal Neoplasms 24 Esophageal Squamous Cell Carcinoma 17 Fallopian Tube Neoplasms 16 Uterine Cervical Neoplasms 15 Lung Neoplasms 11 Carcinoma, Ovarian Epithelial 11 Head and Neck Neoplasms 9 Neoplasms 8 Carcinoma, Squamous Cell 8 Triple Negative Breast Neoplasms 7 Recurrence 6 Neoplasm Metastasis 6 Endometrial Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 5 Nasopharyngeal Neoplasms 5 Advanced Gastric Cancer 5 Pancreatic Neoplasms 4 Hypopharyngeal Neoplasms 4 Oropharyngeal Neoplasms 3 Mouth Neoplasms 3 Laryngeal Neoplasms 3 Carcinoma 3 Anus Neoplasms 3 Unspecified Adult Solid Tumor, Protocol Specific 2 Salivary Gland Neoplasms 2 Prostatic Neoplasms 2

Interventions

genexol-PM 1 brostallicin 1 avelumab 1 Urination 1 Temozolomide 1 Surveys and Questionnaires 1 Sorafenib 1 Propranolol 1 Paclitaxel 1 Molecular Diagnostic Techniques 1 Microarray Analysis 1 Interviews as Topic 1 Doxorubicin 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03512834 2018-07-11

ASAP

Dong-A University Hospital

Phase 2 Unknown

Hemangiosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡